Nuclear Medicine: Page 140

Shine offers new technology to alleviate Mo-99 shortage

By Wayne Forrest

Since the severe global molybdenum-99 (Mo-99) shortage of 2009 and 2010, nuclear medicine practitioners have been glancing back over their collective shoulders to see when the next crisis might occur. Fortunately, plans are in the works to eliminate the angst, with one effort coming from Shine Medical Technologies.

November 12, 2014

2014 11 13 11 18 18 741 Shine Medical Facility Plan 200

How well does BSGI-guided biopsy perform?

By Kate Madden Yee

Wednesday, December 3 | 3:50 p.m.-4:00 p.m. | SSM02-06 | E451ABreast biopsy guided by breast-specific gamma imaging (BSGI) is a viable method for biopsying lesions identified at BSGI but overlooked with mammography or ultrasound, according to this Wednesday afternoon presentation.

November 11, 2014

AuntMinnie.com Molecular Imaging Insider

By Wayne Forrest

November 10, 2014

Navidea reports Q3 revenue growth

By AuntMinnie.com staff writers

Radiopharmaceutical developer Navidea Biopharmaceuticals has released its third-quarter financial results.

November 5, 2014

Road to RSNA 2014: Molecular Imaging Preview

By Wayne Forrest

At the 100th annual meeting of RSNA, molecular imaging and nuclear medicine again will break new ground for an increasing number of clinical applications to better serve patients. Leading the charge is PET/MRI. The hybrid's functional and structural imaging capabilities have captured the imagination of researchers worldwide, resulting in a growing number of scientific research papers this year dedicated to the modality.

November 4, 2014

2014 11 03 11 22 44 485 Road To Rsna 200

PET/MRI compares well with PET/CT for pancreatic cancer

By Wayne Forrest

Thursday, December 4 | 11:40 a.m.-11:50 a.m. | SSQ06-08 | Room E350Italian researchers are adding to the evidence that PET/MRI can benefit cancer patients for use in tumor-node-metastasis staging.

November 4, 2014

PET/MRI adds to lung cancer diagnoses

By Wayne Forrest

Wednesday, December 3 | 11:40 a.m.-11:50 a.m. | SSK18-08 | Room S505ABBritish researchers have concluded that PET/MRI appears to be a "robust technique" for preoperative staging of lung cancer patients, offering "significantly lower radiation dose."

November 4, 2014

Researchers make PET/MRI scans more tolerable for young patients

By Wayne Forrest

Wednesday, December 3 | 11:30 a.m.-11:40 a.m. | SSK18-07 | Room S505ABResearchers at Lucile Packard Children's Hospital and Stanford University School of Medicine have found a way to streamline FDG-PET/MRI scans to make them more tolerable for children with lymphoma and sarcoma.

November 4, 2014

Infants with congenital hyperinsulinism can benefit from PET/MRI

By Wayne Forrest

Wednesday, December 3 | 11:20 a.m.-11:30 a.m. | SSK19-06 | Room S102ABSimultaneous PET/MRI with fluorine-18 dihydroxyphenylalanine matches PET/CT in the preoperative differentiation of congenital hyperinsulinism among pediatric patients -- while delivering less radiation.

November 4, 2014

Time-of-flight PET/MRI could help with a variety of clinical applications

By Wayne Forrest

Wednesday, December 3 | 11:10 a.m.-11:20 a.m. | SSK18-05 | Room S505ABTime-of-flight PET/MRI provided comparable image quality and diagnostic ability to PET/CT in several clinical applications in a study from Stanford University.

November 4, 2014

DOTATOC-PET/CT appears better at sarcoidosis lesion detection

By Wayne Forrest

Tuesday, December 2 | 3:10 p.m.-3:20 p.m. | SSJ20-02 | Room S505ABResearchers were able to detect more lesions in sarcoidosis patients using PET/CT with gallium-68 DOTATOC than conventional gallium-67 citrate scintigraphy in this study from Kyoto University in Japan.

November 4, 2014

PET/MRI provides partial benefit for soft-tissue sarcoma patients

By Wayne Forrest

Sunday, November 30 | 12:05 p.m.-12:15 p.m. | SSA13-09 | Room E451BGerman researchers are lauding the ability of PET/MRI to provide "superior assessment" of therapy based on functional metabolic response, but morphologic information falls short in evaluating therapeutic response in soft-tissue sarcoma patients after isolated limb perfusion.

November 4, 2014

Page 140 of 440